NCT04696640 is a NA clinical trial of Remote Patient Monitoring in Type 1 Diabetes, sponsored by University of California, Davis.

Who is sponsoring NCT04696640?

NCT04696640 is sponsored by University of California, Davis.

What drugs are being tested in NCT04696640?

Interventions in NCT04696640: Remote Patient Monitoring.

What condition does NCT04696640 study?

NCT04696640 studies Type 1 Diabetes.

Is NCT04696640 still recruiting?

NCT04696640 is currently completed. Last updated 2 June 2022.

Last reviewed 2022-06-02 · How we verify

NCT04696640

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes

Completed NA Last updated 2 June 2022

What this trial tests

NA trial testing Remote Patient Monitoring in Type 1 Diabetes in 39 participants. Completed in 25 May 2022.

Timeline

3 June 2021

Primary endpoint
18 April 2022

25 May 2022

Quick facts

Lead sponsor	University of California, Davis
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	sequential
Masking	none
Primary purpose	health services research
Enrollment	39
Start date	3 June 2021
Primary completion	18 April 2022
Estimated completion	25 May 2022
Sites	1 location across United States

Drugs / interventions tested

Remote Patient Monitoring

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →

Sponsor

University of California, Davis

Who can join

Adults 1 to 20, any sex, with Type 1 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project explores the feasibility and utility of remote glucose monitoring for a cohort of children and adolescents with type 1 diabetes (T1D) cared for at UC Davis Health (UCDH).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Remote glucose monitoring is feasible for patients and providers using a commercially available population health platform.
Crossen SS, Romero CC, Lewis C, Glaser NS. · · 2023 · cited 15× · PMID 36817610 · DOI 10.3389/fendo.2023.1063290

Verify or expand the search:

Other trials of Remote Patient Monitoring

Trials testing the same drug.

NCT07115199 — Remote Patient Monitoring for Chronic Hypertension During Pregnancy (REACH) · NA · not yet recruiting
NCT06195839 — Building Engagement Using Financial Incentives Trial - Hypertension · NA · completed
NCT05486962 — Remote Monitoring of Surgical Patients Through VALIDIC · completed
NCT05534932 — Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic Af · NA · active not recruiting
NCT05541120 — Effect of Remote Patient Monitoring and Patient Education on Patient Activation and Glycemic Control in Individuals With · NA · withdrawn

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other University of California, Davis trials

Trials by the same sponsor.

NCT07024498 — Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment · NA · not yet recruiting
NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
NCT07384767 — Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing · Phase 2 · not yet recruiting
NCT07267494 — Image-Guided Herniorrhaphy Study · NA · not yet recruiting
NCT04614714 — Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04696640 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Davis
Last refreshed: 2 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04696640.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing